Medpal AI

What Medpal AI does

MedPal AI plc is a UK-based digital health company that combines a consumer-facing AI health app with integrated pharmacy and clinic services. The firm, headquartered in London and listed on London's AIM market since August 2025 (raising £1.65m net at IPO), operates two interconnected businesses: a freemium mobile app distributed via Apple App Store and Google Play, and a wholly-owned subsidiary called MedPal Limited that runs pharmacy dispensing and clinical consultation services. Customers span general wellness consumers aggregating wearable data, NHS-funded prescription patients, and private weight loss service users; the company has also opened a B2B distribution channel via a partnership with employee benefits firm Epassi.

The MedPal app integrates with hundreds of fitness apps and wearables including Apple Watch, Fitbit, and Oura Ring, aggregating structured health metrics (activity, sleep, heart rate, HRV, respiratory rate) and using AI and machine learning to translate raw data into personalized insights, recommendations, and proactive alerts. A core feature is the AI memory system that retains longitudinal health context per user, complemented by a voice-based conversational health assistant. In December 2025 the company launched a clinical triage service on WhatsApp, built on Google's Vertex AI generative platform, extending the AI surface into a messaging channel and tying into an escalation pathway to licensed clinicians. The pharmacy division, which acquired a facility in Runcorn in April 2026, has scaled from launch to dispensing 147,000 prescriptions in four months and reaching a peak of approximately 41,000 prescription orders in a single month.

Revenue is primarily transaction-based, driven by pharmacy prescription dispensing under NHS contracts and private weight loss services, with subscription revenue from Premium app tiers at $3.99/month or $29.99/year providing a secondary consumer monetization stream. The go-to-market combines product-led growth via app stores with a 30-day free trial, channel partnerships, and direct NHS contracts. The company has expanded internationally with Germany recently launched and the US identified as a future market. Multiple equity vehicles — a £2m ATM facility with Clear Capital (December 2025), a £378,870 ATM drawdown (January 2026), and a £527,000 discounted share placement (March 2026) — are funding pharmacy expansion and growth.

Name

Medpal AI

Legal name

MedPal AI plc

Website

https://medpal.ai

Company type

Public

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

MedPal AI plc is a UK-based digital health company operating an AI-powered consumer health app that aggregates wearable data, alongside integrated pharmacy and clinic services through NHS contracts and private weight loss. Listed on London's AIM in 2025.

Ownership category

akta.pro rank

Product category

Digital Health Platform

NAICS

Software Publishers (5132)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Healthcare & Wellness Personalization (HDAAAGAI)

akta.pro secondary industries

Wearables & Consumer IoT Integration Platforms (BYOD) (HLACAFAF), Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK)

Keywords

• AI health monitoring
• Wearable data aggregation
• Digital health platform
• Pharmacy prescription services
• Personalized health insights

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Marketing or Sales, Personnel, Operations, Supply Chain

Revenue model

1. Pharmacy Prescription Services: Revenue from dispensing prescriptions through NHS contracts and private weight loss services. The company acquired a pharmacy facility in Runcorn and has shown strong prescription volume growth, processing 28,789 prescription orders in November 2025 generating approximately £280,000 in revenue with over 90% month-on-month growth.
2. Premium Subscription: Freemium model with Premium subscription tiers offering additional features. Premium Monthly at $3.99/month or Annual at $29.99/year (equivalent to $2.49/month). Both plans include a 1-month free trial. All features were fully unlocked and free during early access phase.
3. Freemium Consumer Platform: Consumer-facing app distributed via App Store and Google Play with free tier for basic features to drive user acquisition and engagement, monetized through premium upgrades and pharmacy services.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

MedPal AI operates an AI-powered digital health companion app for iOS and Android that aggregates data from hundreds of connected wearables and fitness apps (e.g., Apple Watch, Fitbit, Oura Ring), then uses AI and machine learning to convert raw metrics into personalized health insights, recommendations, real-time alerts, and a voice-based conversational health assistant. Through wholly-owned subsidiary MedPal Limited, it also operates UK pharmacy and clinic services that dispense NHS and private prescriptions, complemented by a Vertex AI-powered WhatsApp clinical triage service. The platform is offered on a freemium model with a 30-day free trial and Premium subscriptions at $3.99/month or $29.99/year.

Product overview

MedPal AI operates a consumer-first digital health platform consisting of a core AI-powered wellness companion app (MedPal) and an integrated pharmacy and clinic division (operated by MedPal Limited). The MedPal app aggregates data from hundreds of connected fitness apps and wearables, delivering AI-generated health insights, personalised recommendations, proactive health monitoring, and a voice-based conversational health assistant. The pharmacy and clinic division, backed by NHS contracts, dispenses prescriptions and provides clinical consultation services with AI triage escalation. A WhatsApp-based clinical triage feature (Vertex AI WhatsApp Triage) extends the platform's reach via a messaging channel. The platform operates on a freemium model (free 30-day trial with Premium at $3.99/month or $29.99/year) and was listed on London's AIM in August 2025 after raising £1.65m.

Differentiator

Problem solved

Functional benefit

Products and services

• MedPal AI Health Companion App AI-powered digital health companion app for iOS and Android that aggregates health data from hundreds of connected fitness apps and wearables (Apple Watch, Fitbit, Oura Ring, etc.), delivers personalized AI-generated insights and lifestyle recommendations, provides real-time alerts, includes a voice-based conversational health assistant, and features a Health Guardian AI agent for proactive monitoring and risk detection. Offered on a freemium model with Premium subscriptions at $3.99/month or $29.99/year.
• Vertex AI WhatsApp Triage AI-powered clinical triage service delivered via WhatsApp and built on Google Vertex AI. Lets users interact with an AI health assistant for initial assessment, navigation, and escalation to licensed healthcare professionals through integrated telehealth services.
• Pharmacy Services (MedPal Limited) Pharmacy division operated by wholly-owned subsidiary MedPal Limited that dispenses prescription medications, including NHS-funded prescriptions and private weight loss treatments. Reached approximately 41,000 prescription orders in a single month, generated £280,000 from 28,789 orders in November 2025, and expanded via acquisition of a pharmacy facility in Runcorn.
• Clinic Services (MedPal Limited)

Quantifiable outcome

• 147,000 prescriptions dispensed in four months
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability11 records

Feature6 records

Partnerships

One partnership is on record.

• EpassicoreChannel Partner/ Reseller/ Distributor · 4 September 2025Existing partnership with employee benefits firm Epassi to offer MedPal AI through corporate employee wellness benefit programs. This partnership represents a B2B channel for reaching employees through workplace wellness initiatives.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Livi: Livi is a European digital GP and telehealth provider offering app-based consultations and prescription services. It is directly comparable to MedPal as a digitally enabled primary-care and prescribing platform combining consumer health apps with regulated clinical services.
• Push Doctor: Push Doctor is a UK digital health platform offering video GP appointments and prescription services. It competes with MedPal for NHS and private virtual-care demand and shares a similar app-led, UK-based care delivery model.
• Huma: Huma is a UK-headquartered digital health platform combining patient apps, remote monitoring, and AI-driven insights for health systems and life sciences. It is directly comparable to MedPal's AI-aggregated health data and remote care approach.
• Doctor Care Anywhere: Doctor Care Anywhere is a UK-listed telehealth and digital health company providing virtual GP consultations and prescription delivery. It is a direct peer to MedPal Limited's clinical and pharmacy services in the UK digital healthcare market.
• Pharmacy2U: Pharmacy2U is the UK's largest online pharmacy, dispensing NHS and private prescriptions at scale. It is a direct peer to MedPal Limited's pharmacy division and represents the scaled incumbent MedPal is trying to disrupt.

Broad incumbents

• Oura: Oura is a smart-ring wearable with an AI-powered membership service offering personalized health insights. It competes with MedPal at the wearable-data-aggregation-and-insights layer for the same consumer segment.
• Whoop: Whoop is a leading wearable health and fitness membership platform combining hardware with AI-driven recovery, strain, and sleep insights. It is a broader incumbent comparable to MedPal on wearable data aggregation and personalized health recommendations.
• Babylon Health: Babylon Health was a UK-founded AI-driven digital health and telehealth platform offering symptom checking, virtual consultations, and prescription services. It is relevant as a historical UK peer that combined the same consumer-AI-plus-clinic-and-prescription model MedPal is pursuing.

Emerging players

• Juniper: Juniper is a UK telehealth subscription service focused on weight management and women's health, offering clinician consultations and prescriptions. It is a focused emerging competitor to MedPal's private weight-loss pharmacy and clinic offering.
• Ada Health: Ada Health is an AI-powered symptom assessment and triage app used by consumers and health systems globally. It is comparable to MedPal as a consumer-facing AI health companion with potential to evolve into a triage and routing platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/medpal-ai

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medpal AI